{"paper_id":"9ee06530-0019-4f3f-8ea8-5ec924d1b0ee","body_text":"Adölesan Endometriozisin Yönetimi\nÖzet\nReferanslar\nLaufer MR, Goitein L, Bush M, et al. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol. 1997;10:199–202\nGoldstein DP, De Cholnoky C, Emans SJ. Adolescent endometriosis. J Adolesc Health Care. 1980;1:37–41\nBenagiano G, Guo SW, Puttemans P, et al. Progress in the diagnosis and management of adolescent endometriosis: an opinion. Reprod Biomed Online. 2018;36:102–114\nJanssen E, Rijkers AC, Hoppenbrouwers K, et al. Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review. Hum Reprod Update. 2013;19:570–582\nMatalliotakis M, Goulielmos GN, Matalliotaki C, et al. Endometriosis in adolescent and young girls: report on a series of 55 cases. J Pediatr Adolesc Gynecol. 2017;30:568–570\nDun EC, Kho KA, Morozov VV, et al. Endometriosis in adolescents. JSLS. 2015;19:e2015.00019\nMartire FG, Lazzeri L, Conway F, et al. Early noninvasive diagnosis of endometriosis: dysmenorrhea and specific ultrasound findings are important indicators in young women. Fertil Steril. 2023;119:455–464\nFallon J. Endometriosis in youth. JAMA. 1946;131:1405–6\nClark AH. Endometriosis in a young girl. J Am Med Assoc. 1948;136(10):690\nLévy JM, Rosenthal R, Dellenbach P, et al. [Genital crisis in the newborn. repercussion of certain maternal or pregnancy factors on the frequency of neonatal metrorrhagia]. Arch Fr Pediatr. 1964;21:819–27\nBryant AE, Laufer MR. Fetal ovarian cysts: incidence, diagnosis and management. J Reprod Med. 2004;49:329–37\nBecker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009\nNnoaham KE, Webster P, Kumbang J, et al. Is early age at menarche a risk factor for endometriosis? A systematic review and meta-analysis of case-control studies. Fertil Steril. 2012;98:702–712.e6\nTreloar SA, Bell TA, Nagle CM, et al. Early menstrual characteristics associated with subsequent diagnosis of endometriosis. Am J Obstet Gynecol. 2010;202:534.e1–534.e6\nSteinmacher S, Bösmüller H, Granai M, et al. Endometriosis in patients with Mayer-Rokitansky-Küster-Hauser-Syndrome-histological evaluation of uterus remnants and peritoneal lesions. J Clin Med. 2022;11:6458\nAsaturova AV, Faizullina NM, Bobkova MV, et al. Morphological features and the functional state of connective tissue of the uterine rudiments in reproductive age patients with Mayer–Rokitansky–Küster–Hauser syndrome. Clin Experimental Morphology. 2020;9(4):24–30\nBoujenah J, Salakos E, Pinto M, et al. Endometriosis and uterine malformations: infertility may increase severity of endometriosis. Acta Obstet Gynecol Scand. 2017;96:702–706\nBrosens I, Gargett CE, Guo SW, et al. Origins and progression of adolescent endometriosis. Reprod Sci. 2016;23:1282–1288\nMalinak LR, Buttram VC Jr., Elias S, et al. Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. Am J Obstet Gynecol. 1980;137:332–337\nYang Y, Wang Y, Yang J, et al. Adolescent endometriosis in China: a retrospective analysis of 63 cases. J Pediatr Adolesc Gynecol. 2012;25:295–299\nDiVasta AD, Vitonis AF, Laufer MR, Missmer SA. Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood. Am J Obstet Gynecol. 2018 Mar;218(3):324.e1-324.e11. doi: 10.1016/j.ajog.2017.12.007.\nGreene R, Stratton P, Cleary SD, et al. Diagnostic experience among 4,334 women reporting surgically diagnosed endometriosis. Fertil Steril. 2009;91:32–39\nKaplanoglu M, Cetin C, Kaplanoglu D, et al. Adolesan Endometriozis. Turkish Journal of Reproductive Medicine and Surgery. 2020;4(1):29–38\nACOG Committee Opinion No. 760. Dysmenorrhea and endometriosis in the adolescent. Obstet Gynecol. 2018;132:e249–58\nMartire FG, Lazzeri L, Conway F, et al. Adolescence and endometriosis: symptoms, ultrasound signs and early diagnosis. Fertil Steril. 2020;114:1049–1057\nSeckin B, Ates MC, Kirbas A, et al. Usefulness of hematological parameters for differential diagnosis of endometriomas in adolescents/young adults and older women. Int J Adolesc Med Health. 2018 Sep 26;33(2). doi: 10.1515/ijamh-2018-0078.\nAlbee RB Jr, Sinervo K, Fisher DT. Laparoscopic excision of lesions suggestive of endometriosis or otherwise atypical in appearance. J Minim Invasive Gynecol. 2008;15(1):32–7\nÖzyer S, Uzunlar Ö, Özcan N, et al. Endometriomas in adolescents and young women. J Pediatr Adolesc Gynecol. 2013;26(3):176–9\nSuvitie PA, Hallamaa MK, Matomäki JM, et al. Prevalence of pain symptoms suggestive of endometriosis among Finnish adolescent girls (TEENMAPS study). J Pediatr Adolesc Gynecol. 2016;29:97–103\nZannoni L, Giorgi M, Spagnolo E, et al. Dysmenorrhea, absenteeism from school, and symptoms suspicious for endometriosis in adolescents. J Pediatr Adolesc Gynecol. 2014;27:258–265\nSöderman L, Edlund M, Marions L. Prevalence and impact of dysmenorrhea in Swedish adolescents. Acta Obstet Gynecol Scand. 2019;98:215–221\nSmorgick N, Marsh CA, As-Sanie S, et al. Prevalence of pain syndromes, mood conditions, and asthma in adolescents and young women with endometriosis. J Pediatr Adolesc Gynecol. 2013;26:171–175\nVentolini G, Horowitz GM, Long R. Endometriosis in adolescence: a long-term follow-up fecundability assessment. Reprod Biol Endocrinol. 2005;3:14\nAudebert A, Lecointre L, Afors K, et al. Adolescent endometriosis: report of a series of 55 cases with a focus on clinical presentation and long-term issues. J Minim Invasive Gynecol. 2015;22:834–840\nChapron C, Lafay-Pillet MC, Monceau E, et al. Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis. Fertil Steril. 2011;95:877–88\nGalinkin J, Koh JL. Recognition and management of iatrogenically induced opioid dependence and withdrawal in children. Pediatrics. 2014;133:152–5\nAllen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal antiinflammatory drugs for pain in women with endometriosis. Cochrane Data-base of Systematic Reviews 2009, Issue 2\nMarjoribanks J, Ayeleke RO, Farquhar C, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015;(7):CD001751\nProctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332(7550):1134–8\nBrown J, Crawford TJ, Datta S, et al. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2018;5:CD001019\nHarada T, Momoeda M, Taketani Y, et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis. Fertil Steril. 2008;90:1583–1588\nZorbas KA, Economopoulos KP, Vlahos NF. Continuous versus cyclic oral contraceptives for the treatment of endometriosis. Arch Gynecol Obstet. 2015;292:37–43\nOlive DL. Medical therapy of endometriosis. Semin Reprod Med. 2003;21(2):167–78\nPractice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116:223–236\nBrown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev. 2012;CD002122\nFlores VA, Vanhie A, Dang T, et al. Progesterone receptor status predicts response to progestin therapy in endometriosis. J Clin Endocrinol Metab. 2018;103:4561–4568\nChronic Pelvic Pain: ACOG Practice Bulletin, Number 218. Obstet Gynecol. 2020;135(3):e98–e109\nGallagher JS, Missmer SA, Hornstein MD, et al. Long-term effects of gonadotropin-releasing hormone agonists and add-back in adolescent endometriosis. J Pediatr Adolesc Gynecol. 2018;31:376–381\nSadler Gallagher J, Feldman HA, Stokes NA, et al. The effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life for adolescents with endometriosis. J Pediatr Adolesc Gynecol. 2017;30:215–222\nDiVasta AD, Feldman HA, Sadler Gallagher J, et al. Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis. Obstet Gynecol. 2015;126:617–627\nAshfaq S, Pellegrini MV, Can AS. Danazol. In: StatPearls [Internet]. 2024\nLaufer MR, Sanfilippo J, Rose G. Adolescent endometriosis: diagnosis and treatment approaches. J Pediatr Adolesc Gynecol. 2003;16(suppl 3):S3–S11\nShi J, Tan X, Feng G, et al. Research advances in drug therapy of endometriosis. Front Pharmacol. 2023;14:1199010\nChwalisz K. Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix. F S Rep. 2023;4(2 Suppl):65–72\nNothnick WB. The emerging use of aromatase inhibitors for endometriosis treatment. Reprod Biol Endocrinol. 2011;9:87\nAbbott J, Hawe J, Hunter D, et al. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004;82:878–884\nTandoi I, Somigliana E, Riparini J, et al. High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol. 2011;24:376–379\nBerlanda N, Vercellini P, Fedele L. The outcomes of repeat surgery for recurrent symptomatic endometriosis. Curr Opin Obstet Gynecol. 2010;22(4):320–5\nSeo JW, Lee DY, Yoon BK, et al. The efficacy of postoperative cyclic oral contraceptives after gonadotropin-releasing hormone agonist therapy to prevent endometrioma recurrence in adolescents. J Pediatr Adolesc Gynecol. 2017;30:223–227\nDoyle JO, Missmer SA, Laufer MR. The effect of combined surgical-medical intervention on the progression of endometriosis in an adolescent and young adult population. J Pediatr Adolesc Gynecol. 2009;22:257–263","source_license":"CC0","license_restricted":false}